The Swiss ILD Cohort is supported by a combination of public and private funding sources, as well as national and international research collaborations.
Public funding
Swiss National Science Foundation (SNF), EU Horizon and academic institutions
Industry support
Bristol Myers Squibb (BMS) and Boehringer Ingelheim
Governance and indipendence
The Swiss Society of Pulmonology (SSP) acts as a steering and oversight body for the cohort. Scientific independence and data governance are ensured through centralized oversight by the Steering Committee, the Sponsor, and the Scientific Advisory Board, in accordance with applicable ethical and regulatory standards.
